Incyte Corporation (LON:0J9P)
London · Delayed Price · Currency is GBP · Price in USD 101.01
+0.21 (0.21%)
Jan 29, 2026, 9:41 AM GMT
Incyte Market Cap
Incyte has a market cap or net worth of 14.42 billion as of January 29, 2026. Its market cap has increased by 29.45% in one year.
Market Cap
14.42B
Enterprise Value
12.32B
Revenue
3.58B
Ranking
n/a
PE Ratio
16.31
Stock Price
101.01
Market Cap Chart
Since November 4, 1993, Incyte's market cap has increased from 30.86M to 14.42B, an increase of 46,630.60%. That is a compound annual growth rate of 21.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 14.76B | 2.42% |
| Dec 31, 2025 | 14.41B | 35.55% |
| Dec 31, 2024 | 10.63B | -3.79% |
| Dec 29, 2023 | 11.05B | -25.51% |
| Dec 30, 2022 | 14.83B | 23.86% |
| Dec 31, 2021 | 11.97B | -14.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.27B |
| GSK plc | 74.73B |
| Haleon | 33.54B |
| Smith & Nephew | 10.56B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.42B |
| Genus | 1.99B |
| HUTCHMED (China) | 1.90B |